Why the study?
Does a single oral dose of narbivolol (R 67555) alter exercise-induced hemodynamic responses compared to atenolol, pindolol, and propranolol in normal volunteers?
Does a single oral dose of narbivolol (R 67555) alter exercise-induced hemodynamic responses compared to atenolol, pindolol, and propranolol in normal volunteers?
A single oral dose of the new beta-1-adrenoceptor blocking agent narbivolol (R 67555) lowers exercise-induced blood pressure similarly to established beta-blockers but with less heart rate reduction.
Nebivolol attenuates exercise hemodynamics with less chronotropy than comparators; leaves open advantages in hypertensive patients.
In eight normal volunteers R 67555 at 5 mg and 10 mg significantly lowered the exercise‐induced increase of systolic blood pressure by 20 and 25%, and the exercise‐induced increase of heart rate by 20 and 21% respectively. The blood pressure lowering effect of R 67555 6 hr after intake was comparable to that observed after atenolol, pindolol, and propranolol. In contrast, the lowering of exercise‐induced increase of heart rate was significantly less with R 67555 than with the other beta‐blockers tested. The ratio of PEP c /LVET c , a measure of left ventricular performance, significantly increased 3 hr after intake aof atenolol, propranolol, and 10 mg of R 67555 but not after pindolol and 5 mg of R 67555. Six hr after administration of pindolol and of 5 mg of R 67555, the ratio PEP C /LVET c was significantly lowered as compared with control values. The post‐exercise left ventricular ejection time (LVET c ) significantly shortened 3 hr and 6 hr after intake of 5 mg and 10 mg of R 67555, whereas a trend to prolongation was observed after administration of atenolol, pindolol, and propranolol.
No takes yet. Share an insight, caveat, or question.
Crée et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: